These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 3056807)
1. Biosynthetic human proinsulin, a new therapeutic compound for diabetics? A comparative study of biosynthetic human proinsulin with biosynthetic human insulin. Rosak C; Boehm BO; Althoff PH; Schöffling K Horm Metab Res Suppl; 1988; 18():16-21. PubMed ID: 3056807 [TBL] [Abstract][Full Text] [Related]
2. Comparative study of hormonal counterregulation during GCIIS-guided hypoglycemia tests using human proinsulin and human insulin (recombinant DNA). Müller-Esch G; von der Lühe C; Ball P; Henkel E; Schlüter KJ; Wood WG; Scriba PC Horm Metab Res Suppl; 1988; 18():24-33. PubMed ID: 2847967 [TBL] [Abstract][Full Text] [Related]
3. Metabolic effects of intravenous proinsulin. Petersen KG; Storch M; Schuler G; Kerp L Horm Metab Res Suppl; 1988; 18():68-73. PubMed ID: 3056815 [TBL] [Abstract][Full Text] [Related]
4. Hypoglycemia following insulin and proinsulin. A comparison. Petersen KG; Licht T; Storch M; Pilot PR; Alexopoulos A; Lehmann M; Weigel S; Kerp L Horm Metab Res; 1986 Aug; 18(8):530-4. PubMed ID: 3530932 [TBL] [Abstract][Full Text] [Related]
5. Effect of a two hour proinsulin infusion on the glucose lowering potency of a following insulin injection. Hübinger A; Randerath W; Tosetti P; Schlüter KJ; Gries FA Horm Metab Res Suppl; 1988; 18():34-7. PubMed ID: 3056809 [TBL] [Abstract][Full Text] [Related]
6. Hypoglycemic effect of subcutaneously injected biosynthetic human proinsulin in healthy man. Pycior M; Kemmer FW; Berger M Horm Metab Res Suppl; 1988; 18():22-4. PubMed ID: 3056808 [TBL] [Abstract][Full Text] [Related]
7. Effects of single and combined infusions of human biosynthetic proinsulin and insulin on glucose metabolism and on plasma hormone concentrations in euglycaemic clamp experiments. Nauck MA; Stöckmann F; Thiery J; Ebert R; Creutzfeldt W Horm Metab Res Suppl; 1988; 18():60-7. PubMed ID: 3056814 [TBL] [Abstract][Full Text] [Related]
8. Human proinsulin: bioactivity and pharmaco-kinetics after intravenous and subcutaneous administration. Schatz H; Ammermann S Horm Metab Res Suppl; 1988; 18():1-5. PubMed ID: 3056805 [TBL] [Abstract][Full Text] [Related]
9. Kinetics of biosynthetic human proinsulin in patients with terminal renal insufficiency. Zilker TR; Rebel C; Kopp KF; Wahl K; Ermler R; Heinzel G; Hales CN; Bottermann P Horm Metab Res Suppl; 1988; 18():43-8. PubMed ID: 3056810 [TBL] [Abstract][Full Text] [Related]
10. Hormonal and metabolic parameters following insulin-induced hypoglycemia. Rosak C; Vogel D; Althoff PH; Neubauer M; Brecht HM; Schöffling K Endokrinologie; 1982 Jul; 79(3):337-44. PubMed ID: 6751813 [TBL] [Abstract][Full Text] [Related]
11. Bioactivity and pharmacokinetics of human proinsulin in comparison to human insulin after intravenous and subcutaneous injection. Schatz H; Ammermann S; Laube H; Federlin K Horm Metab Res; 1988 Jul; 20(7):445-9. PubMed ID: 3049293 [TBL] [Abstract][Full Text] [Related]
12. Action profile of biosynthetic human proinsulin trials with the BIOSTATOR in metabolically normal subjects. Bottermann P; Wahl K; Ermler R; Gray IP; Hales CN Horm Metab Res Suppl; 1988; 18():6-11. PubMed ID: 3056813 [TBL] [Abstract][Full Text] [Related]
13. Hypoglycaemic effect of proinsulin and insulin in intact and eviscerated rats. Kramer U; Hartmann H; Creutzfeldt W Horm Metab Res Suppl; 1988; 18():56-60. PubMed ID: 3056812 [TBL] [Abstract][Full Text] [Related]
14. The metabolic response to insulin deprivation in idiopathic brittle diabetes. Husband DJ; Pernet A; Gill GV; Hanning I; Alberti KG Diabetes Res; 1986 May; 3(4):193-8. PubMed ID: 3527516 [TBL] [Abstract][Full Text] [Related]
15. Investigation of the prolonged hypoglycemic effect of human proinsulin in diabetes mellitus. Laube H; Pinter W; Federlin K Horm Metab Res Suppl; 1988; 18():12-5. PubMed ID: 3056806 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of recombinant human insulin-like growth factor-I and insulin on glucose and leucine kinetics in humans. Laager R; Ninnis R; Keller U J Clin Invest; 1993 Oct; 92(4):1903-9. PubMed ID: 8408642 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of biosynthetic human proinsulin following intravenous and subcutaneous administration in metabolically healthy volunteers. Zilker TR; Gray IP; Hales CN; Wahl K; Ermler R; Lebender A; Heinzel G; Bottermann P Horm Metab Res Suppl; 1988; 18():37-43. PubMed ID: 3192159 [TBL] [Abstract][Full Text] [Related]
18. Proinsulin as a possible therapeutic agent. Hadjidakis DJ; Raptis SA Horm Metab Res Suppl; 1992; 26():131-7. PubMed ID: 1490681 [TBL] [Abstract][Full Text] [Related]
19. Counterregulatory hormone responses and symptoms during hypoglycaemia induced by porcine, human regular insulin, and Lys(B28), Pro(B29) human insulin analogue (insulin Lispro) in healthy male volunteers. Jacobs MA; Salobir B; Popp-Snijders C; Ader H; Heine RJ Diabet Med; 1997 Mar; 14(3):248-57. PubMed ID: 9088775 [TBL] [Abstract][Full Text] [Related]
20. The effects of human proinsulin on glucose turnover and intermediary metabolism in insulin-dependent-diabetes mellitus. Davis SN; Ansiferov M; Hetherington C; Brown M; Branch WJ; Hales CN; Orskov H; Alberti KG J Clin Endocrinol Metab; 1992 Nov; 75(5):1282-8. PubMed ID: 1430089 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]